GPhA joins the Partnership for Safe Medicines
WASHINGTON The lobby for the generic drug industry is joining the fight against counterfeit drugs.
The Generic Pharmaceutical Association announced Tuesday that it had joined the Partnership for Safe Medicines, which works to protect the global prescription drug supply chain from counterfeit and contraband drugs.
“GPhA and its member companies are committed to medicines of the highest quality, safety and effectiveness,” a statement by GPhA read. “We are pleased to add our voice to those of PSM members working to inform consumers, healthcare professionals and policy-makers about the dangers of counterfeit medicines.”
‘C’-ing that scars go away
GUILFORD, Conn. —Mitchell-Vance Labs is in the process of launching a new scar product to add to its ScarAway offering that could appeal to a whole new consumer in search of scar therapy—ScarAway for C-sections.
The therapy may have direct appeal to 1-in-4 new mothers, which is the number of women who give birth by Cesarean section in the United States. According to the March of Dimes, the national weighted average of C-section births is 25.2%, but the percentage of C-sections performed climbs higher than 30% in three states—Mississippi (31.1%), New Jersey (30.9%) and Louisiana (30.4%).
The product features an extended-length, medical-grade silicon scar sheet ideal for placement over C-section cuts.
CRN head counters attacks on industry
MCLEAN, Va USA Today opinion piece published last month regarding a Consumer Reports attack on the dietary supplement industry. —The Council for Responsible Nutrition’s president and CEO Steve Mister supplied the “opposing view” to a
At issue was the public misconception that dietary supplements are unregulated. “While many users believe that sale of unsafe or ineffective supplements must be illegal, it is not,” USA Today opined, citing Consumer Reports. “The public has little protection from useless, fraudulent, dangerous or even deadly products, thanks to special protection Congress gave the industry in 1994.”
“Truth is, the Food and Drug Administration already has ample authority to regulate this industry,” Mister countered. Opinions of regulation aside, Consumer Reports had outlined problems with a dozen considered-to-be-dangerous herbal supplements—none of which would make any mass retailer’s best-seller list.
“The media circus surrounding the latest issue of Consumer Reports implicates the entire aisle of mainstream dietary supplements based on 12 ingredients that, combined, make up less than 1% of the marketplace,” Mister noted. “Yet given the attention, one would think these 12 herbs represent the mainstream dietary supplement aisle at your neighborhood pharmacy. They do not.” Mister added, “If any of these 12 ingredients is truly unsafe, then the FDA should ban its use.”